Cargando…
Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient
We report a case of refractory secondary ocular hypertension after insertion of dexamethasone implant (OZURDEX) for posterior uveitis in a young patient, which necessitated removal of the implant through pars plana vitrectomy along with a trabeculectomy. A young male developed secondary ocular hyper...
Autores principales: | David, Rathini Lilian, Sen, Parveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394078/ https://www.ncbi.nlm.nih.gov/pubmed/32792805 http://dx.doi.org/10.4103/ojo.OJO_40_2018 |
Ejemplares similares
-
Intravitreal Dexamethasone Implant (Ozurdex) in Coats’ Disease
por: Saatci, Ali Osman, et al.
Publicado: (2013) -
Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
por: Aljohani, Saud M., et al.
Publicado: (2021) -
A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
por: Eris, Erdem, et al.
Publicado: (2017) -
Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa
por: Örnek, Nurgül, et al.
Publicado: (2016) -
Active removal of anterior segment-migrated dexamethasone implant (Ozurdex(®))
por: Depla, Jozef Adelson M., et al.
Publicado: (2022)